NCT04643145

Brief Summary

Flexible ureterorenoscopy (FURS) is now recommended for the treatment of kidney stones smaller than 20 mm, as an alternative to extracorporeal shock wave lithotripsy (ESWL) and in combination with percutanous nephrolithotomy (PCNL) for stones larger than 20 mm. At the end of the operation, a ureteral drainage is put in place for the treatment of residual fragments and the inflammation following the ureteroscopy. It helps prevent obstructive symptoms and the development of strictures. Drainage is done either by a ureteral catheter or by a double J stent. In the literature, while drainage after ureteroscopy is recommended, the criteria for choosing between these two options are not clearly defined. The objective of this study will be to assess whether the type of postoperative drainage after URS for kidney stones can influence the perioperative outcomes and health-related quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 24, 2020

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

April 11, 2023

Status Verified

April 1, 2023

Enrollment Period

4.8 years

First QC Date

November 21, 2020

Last Update Submit

April 8, 2023

Conditions

Keywords

Kidney stonesFlexible ureteroscopyQuality of lifedrainage

Outcome Measures

Primary Outcomes (1)

  • Stone free rate

    presence of residual fragments on non contrast computed tomography

    12 weeks after the procedure

Secondary Outcomes (2)

  • perioperative complications

    First 3 days postoperative

  • Postoperative pain by visual analogue scale

    first 24 hours postoperatively

Study Arms (2)

Ureteral catheter

ACTIVE COMPARATOR

This group will receive ureteral catheter for 2 days after the procedure

Procedure: Flexible ureteroscopy for renal calculi less than 20 mm

Indwelling double J stent

ACTIVE COMPARATOR

This group will receive indwelling double J stent for 2-4 weeks after the procedure

Procedure: Flexible ureteroscopy for renal calculi less than 20 mm

Interventions

Patients with renal calculi less than 20 mm will be managed by flexible ureteroscopy. at the end of the procedure, they will be randomized to receive either temporary ureteral catheter for 2 days or indweeling double J stent for 2-4 weeks

Indwelling double J stentUreteral catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (aged \>18 years) 2- Undergo unilateral uncomplicated retrograde intrarenal surgery (RIRS) using flexible ureterorenoscopy.

You may not qualify if:

  • Residual ureteral or renal stones after the procedure as documented by the surgeon
  • Patients who will need auxiliary procedures (ESWL , re-FURS or PCNL)
  • Preoperative febrile UTI
  • pregnancy or breastfeeding
  • Bilateral ureteroscopic surgery
  • Single kidney
  • Chronic kidney disease
  • Cardiovascular or cerebrovascular disease
  • Hepatic dysfunction
  • Other acute medical conditions as acute gastroenteritis, osetoarthritis that might influence the patient QoL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology and Nephrology Center

Al Mansurah, DK, 35516, Egypt

Location

MeSH Terms

Conditions

Kidney Calculi

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Amr A Elsawy

    Mansoura University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 21, 2020

First Posted

November 24, 2020

Study Start

March 1, 2020

Primary Completion

December 1, 2024

Study Completion

December 15, 2024

Last Updated

April 11, 2023

Record last verified: 2023-04

Locations